Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
- USD | -.--% | +0.14% | -0.05% |
2020 | The Medicines Company Announces Board Changes | CI |
2020 | The Medicines Company(NasdaqGS:MDCO) dropped from S&P 600 Health Care | CI |
Sales 2017 | 44.79M 3.74B | Sales 2018 | 6.14M 512M | Capitalization | 1.41B 117B |
---|---|---|---|---|---|
Net income 2017 | -708M -59.06B | Net income 2018 | -123M -10.26B | EV / Sales 2017 | 55.1 x |
Net Debt 2017 | 498M 41.53B | Net Debt 2018 | 552M 46.03B | EV / Sales 2018 | 319 x |
P/E ratio 2017 |
-2.79
x | P/E ratio 2018 |
-11.4
x | Employees | - |
Yield 2017 * |
-
| Yield 2018 |
-
| Free-Float | 92.97% |
Managers | Title | Age | Since |
---|---|---|---|
Krishna Gorti
IRC | Investor Relations Contact | - | - |
Stephen M. Rodin
LAW | General Counsel | 47 | - |
Members of the board | Title | Age | Since |
---|---|---|---|
John C. Kelly
BRD | Director/Board Member | 81 | - |
1st Jan change | Capi. | |
---|---|---|
-0.05% | 6.79B | |
+15.91% | 41.97B | |
+22.40% | 22.34B | |
+18.48% | 15.25B | |
+16.12% | 14B | |
+45.12% | 12.06B | |
-9.58% | 6.8B | |
-8.87% | 5.73B | |
+14.18% | 5.49B | |
+4.00% | 4.62B |
- Stock Market
- Equities
- MDCO Stock